Download PDF
Int J Angiol 2014; 23(02): 085-092
DOI: 10.1055/s-0034-1370885
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Role of Imaging in Hypertensive Heart Disease

Edward T. D. Hoey
1   Department of Radiology, Heart of England NHS Foundation Trust, Birmingham, United Kingdom
,
Vijayabhaskar Pakala
1   Department of Radiology, Heart of England NHS Foundation Trust, Birmingham, United Kingdom
,
Jun K. Teoh
2   Department of Cardiology, Heart of England NHS Foundation Trust, Birmingham, United Kingdom
,
Helen Simpson
2   Department of Cardiology, Heart of England NHS Foundation Trust, Birmingham, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
09 June 2014 (online)

    Permissions and Reprints

Abstract

Hypertensive heart disease (HHD) describes a spectrum of target organ response that includes left ventricular hypertrophy, systolic, and diastolic dysfunction. A variety of imaging techniques can be used to assess the various aspects of HHD. Echocardiography has for many years been the main imaging technique in the evaluation of HHD, but there is an increasing role for cardiovascular magnetic resonance (CMR) imaging due to its ability to provide an unrestricted field of view and noninvasive tissue characterization. This article reviews the current role of imaging for HHD with particular focus on echocardiography and CMR applications.

Keywords

echocardiography - magnetic resonance imaging - hypertension
 

  • References

  • 1 Drazner MH. The progression of hypertensive heart disease. Circulation 2011; 123 (3) 327-334
    Google Scholar
  • 2 Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322 (22) 1561-1566
    CrossrefPubMedGoogle Scholar
  • 3 Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117 (3) 568-575
    CrossrefPubMedGoogle Scholar
  • 4 Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55 (4) 613-618
    CrossrefPubMedGoogle Scholar
  • 5 Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension 2004; 44 (2) 175-179
    CrossrefPubMedGoogle Scholar
  • 6 Devereux RB, Wachtell K, Gerdts E , et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 292 (19) 2350-2356
    CrossrefPubMedGoogle Scholar
  • 7 Ganau A, Devereux RB, Roman MJ , et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19 (7) 1550-1558
    CrossrefPubMedGoogle Scholar
  • 8 Ross Jr J. On variations in the cardiac hypertrophic response to pressure overload. Circulation 1997; 95 (6) 1349-1351
    CrossrefPubMedGoogle Scholar
  • 9 Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969; 71 (1) 89-105
    CrossrefPubMedGoogle Scholar
  • 10 Pewsner D, Jüni P, Egger M, Battaglia M, Sundström J, Bachmann LM. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ 2007; 335 (7622): 711
    CrossrefPubMedGoogle Scholar
  • 11 Salcedo EE, Gockowski K, Tarazi RC. Left ventricular mass and wall thickness in hypertension. Comparison of M mode and two dimensional echocardiography in two experimental models. Am J Cardiol 1979; 44 (5) 936-940
    CrossrefPubMedGoogle Scholar
  • 12 Devereux RB, Alonso DR, Lutas EM , et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57 (6) 450-458
    CrossrefPubMedGoogle Scholar
  • 13 Li L, Shigematsu Y, Hamada M, Hiwada K. Relative wall thickness is an independent predictor of left ventricular systolic and diastolic dysfunctions in essential hypertension. Hypertens Res 2001; 24 (5) 493-499
    CrossrefPubMedGoogle Scholar
  • 14 Kühl HP, Schreckenberg M, Rulands D , et al. High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004; 43 (11) 2083-2090
    CrossrefPubMedGoogle Scholar
  • 15 Grothues F, Smith GC, Moon JC , et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002; 90 (1) 29-34
    CrossrefPubMedGoogle Scholar
  • 16 Rudolph A, Abdel-Aty H, Bohl S , et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 2009; 53 (3) 284-291
    CrossrefPubMedGoogle Scholar
  • 17 Ho CY, López B, Coelho-Filho OR , et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010; 363 (6) 552-563
    CrossrefPubMedGoogle Scholar
  • 18 Moon JC, Sachdev B, Elkington AG , et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003; 24 (23) 2151-2155
    CrossrefPubMedGoogle Scholar
  • 19 Smedema JP, Snoep G, van Kroonenburgh MP , et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45 (10) 1683-1690
    CrossrefPubMedGoogle Scholar
  • 20 Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis 2010; 52 (4) 347-361
    CrossrefPubMedGoogle Scholar
  • 21 Maceira AM, Joshi J, Prasad SK , et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005; 111 (2) 186-193
    CrossrefPubMedGoogle Scholar
  • 22 Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008; 10: 54-65
    CrossrefPubMedGoogle Scholar
  • 23 Petersen SE, Selvanayagam JB, Francis JM , et al. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2005; 7 (3) 551-558
    CrossrefPubMedGoogle Scholar
  • 24 Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH. Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation 1991; 83 (5) 1676-1684
    CrossrefPubMedGoogle Scholar
  • 25 Rosen BD, Saad MF, Shea S , et al. Hypertension and smoking are associated with reduced regional left ventricular function in asymptomatic: individuals the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol 2006; 47 (6) 1150-1158
    CrossrefPubMedGoogle Scholar
  • 26 Redfield MM, Jacobsen SJ, Burnett Jr JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289 (2) 194-202
    CrossrefPubMedGoogle Scholar
  • 27 Smith VE, White WB, Meeran MK, Karimeddini MK. Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. J Am Coll Cardiol 1986; 8 (6) 1449-1454
    CrossrefPubMedGoogle Scholar
  • 28 Mattioli AV, Bonatti S, Monopoli D, Zennaro M, Mattioli G. Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension. Blood Press 2005; 14 (5) 273-278
    CrossrefPubMedGoogle Scholar
  • 29 Tsang TS, Abhayaratna WP, Barnes ME , et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter?. J Am Coll Cardiol 2006; 47 (5) 1018-1023
    CrossrefPubMedGoogle Scholar
  • 30 Ishida Y, Meisner JS, Tsujioka K , et al. Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation 1986; 74 (1) 187-196
    CrossrefPubMedGoogle Scholar
  • 31 Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30 (6) 1527-1533
    CrossrefPubMedGoogle Scholar
  • 32 Narayanan A, Aurigemma GP, Chinali M, Hill JC, Meyer TE, Tighe DA. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study. Circ Cardiovasc Imaging 2009; 2 (5) 382-390
    CrossrefPubMedGoogle Scholar
  • 33 Chai P, Mohiaddin R. How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping. J Cardiovasc Magn Reson 2005; 7 (4) 705-716
    CrossrefPubMedGoogle Scholar
  • 34 Moreo A, Ambrosio G, De Chiara B , et al. Influence of myocardial fibrosis on left ventricular diastolic function: non-invasive assessment by CMR and echo. Circ Cardiovasc Imaging 2009; 2 (6) 437-443
    CrossrefPubMedGoogle Scholar
  • 35 Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001; 135 (6) 401-411
    CrossrefPubMedGoogle Scholar
  • 36 Hom JJ, Ordovas K, Reddy GP. Velocity-encoded cine MR imaging in aortic coarctation: functional assessment of hemodynamic events. Radiographics 2008; 28 (2) 407-416
    CrossrefPubMedGoogle Scholar
  • 37 Blake MA, Kalra MK, Maher MM , et al. Pheochromocytoma: an imaging chameleon. Radiographics 2004; 24 (Suppl. 01) S87-S99
    CrossrefPubMedGoogle Scholar